Clinical Trial Update: Evaluation of Polygenic Risk Score for Epithelial OVarian cancEr Risk Prediction: the PROVE Study

View source ↗

Summary

This document reports an ongoing clinical trial (PROVE) evaluating a polygenic risk score to predict epithelial ovarian cancer risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Ovarian Cancer

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Ovarian Cancer | Status: RECRUITING